In summary, we have demonstrated herein that administration of genipin attenuates hyperglycemia-induced podocyte lesion and therefore delays the progression of diabetic nephropathy through negatively regulation of UCP2 protein expression. Here, UCP2 is linked to diabetic kidney disease.